Who makes Covax-19™?

Covax-19™ is developed by GeneCure Biotechnologies.

Last reviewed 2026-04-19 · How we verify

Covax-19™

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

GeneCure Biotechnologies · Phase 1 active Biologic

At a glance

Generic name	Covax-19™
Sponsor	GeneCure Biotechnologies
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Covax-19™ CI brief — competitive landscape report
Covax-19™ updates RSS · CI watch RSS
GeneCure Biotechnologies portfolio CI